You are viewing an incomplete version of our website. Please click to reload the website as full version.

MLX Interacting Protein-Like (MLXIPL) antibody

Details for Product No. ABIN558896, Supplier: Login to see
Antigen
  • ChREBP
  • MLXIPL
  • CHREBP
  • MIO
  • MONDOB
  • WBSCR14
  • WS-bHLH
  • bHLHd14
  • Wbscr14
Reactivity
Human
58
23
20
3
1
1
1
1
1
Host
Rabbit
55
4
Clonality
Polyclonal
Conjugate
Un-conjugated
4
4
3
2
2
2
1
1
1
1
1
1
1
1
1
Application
Immunofluorescence (IF), Western Blotting (WB)
43
21
21
11
10
10
8
3
2
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Available images

Cross-Reactivity Mouse (Murine), Rat (Rattus)
Purification Aff - Purified
Alternative Name MLXIPL (MLXIPL Antibody Abstract)
Pathways
Restrictions For Research Use only
Format Liquid
Supplier Images
 image for anti-MLX Interacting Protein-Like (MLXIPL) antibody (ABIN558896) anti-MLX Interacting Protein-Like (MLXIPL) antibody
Product cited in: Heichman, Roberts: "Rules to replicate by." in: Cell, Vol. 79, Issue 4, pp. 557-62, 1994 (PubMed).

Sherr: "G1 phase progression: cycling on cue." in: Cell, Vol. 79, Issue 4, pp. 551-5, 1994 (PubMed).

Peter, Herskowitz: "Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle." in: Cell, Vol. 79, Issue 2, pp. 181-4, 1994 (PubMed).

Background publications Xiong, Zhang, Beach: "Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation." in: Genes & development, Vol. 7, Issue 8, pp. 1572-83, 1993 (PubMed).

Hunter, Pines: "Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age." in: Cell, Vol. 79, Issue 4, pp. 573-82, 1994 (PubMed).